EXcerpt: "This entire mechanism relies on the ability to detect and monitor the change in PD-L1 expression, which is where the Creatv Bio LifeTracDx liquid biopsy becomes indispensable:Baseline & Monitoring: The test provides a real-time, non-invasive assessment of PD-L1 expression on CTCs and CAMLs before leronlimab treatment, confirming if the tumor is initially "cold" (low PD-L1).11Confirmation of Priming: It allows for monitoring post-leronlimab treatment to confirm the upregulation of PD-L1.12 This is a crucial step in the proposed protocol to identify patients who have been successfully primed and are now candidates for an ICI."

I know nothing of Creatv. Is its science and testing technology unchallenged and accepted throughout the entire medical community? If so, this is a real breakthrough for LL and cancer patients everywhere.